Abstract:Up-regulation of the collagenolytic membrane type-1 matrix metalloproteinase (MT1-MMP) leads to increased MMP2 (gelatinase A) activation and MT1-MMP autolysis. The autocatalytic degradation product is a cell surface 44-kDa fragment of MT1-MMP (Gly285–Val582) in which the ectodomain consists of only the linker, hemopexin C domain and the stalk segment found before the transmembrane sequence. In the collagenases, hemopexin C domain exosites bind native collagen, which is required for triple helicase activity during collagen cleavage. Here we investigated the collagen binding properties and the role of the hemopexin C domain of MT1-MMP and of the 44-kDa MT1-MMP ectodomain in collagenolysis. Recombinant proteins, MT1-LCD (Gly285–Cys508), consisting of the linker and the hemopexin C domain, and MT1-CD (Gly315–Cys508), which consists of the hemopexin C domain only, were found to bind native type I collagen but not gelatin. Functionally, MT1-LCD inhibited collagen-induced MMP2 activation in fibroblasts, suggesting that interactions between collagen and endogenous MT1-MMP directly stimulate the cellular activation of pro-MMP2. MT1-LCD, but not MT1-CD, also blocked the cleavage of native type I collagen by MT1-MMP in vitro, indicating an important role for the MT1-MMP linker region in triple helicase activity. Similarly, soluble MT1-LCD, but not MT1-CD or peptide analogs of the MT1-MMP linker, reduced the invasion of type I collagen matrices by MDA-MB-231 cells as did the expression of recombinant 44-kDa MT1-MMP on the cell surface. Together, these studies demonstrate that generation of the 44-kDa MT1-MMP autolysis product regulates collagenolytic activity and subsequent invasive potential, suggesting a novel feedback mechanism for the control of pericellular proteolysis. Up-regulation of the collagenolytic membrane type-1 matrix metalloproteinase (MT1-MMP) leads to increased MMP2 (gelatinase A) activation and MT1-MMP autolysis. The autocatalytic degradation product is a cell surface 44-kDa fragment of MT1-MMP (Gly285–Val582) in which the ectodomain consists of only the linker, hemopexin C domain and the stalk segment found before the transmembrane sequence. In the collagenases, hemopexin C domain exosites bind native collagen, which is required for triple helicase activity during collagen cleavage. Here we investigated the collagen binding properties and the role of the hemopexin C domain of MT1-MMP and of the 44-kDa MT1-MMP ectodomain in collagenolysis. Recombinant proteins, MT1-LCD (Gly285–Cys508), consisting of the linker and the hemopexin C domain, and MT1-CD (Gly315–Cys508), which consists of the hemopexin C domain only, were found to bind native type I collagen but not gelatin. Functionally, MT1-LCD inhibited collagen-induced MMP2 activation in fibroblasts, suggesting that interactions between collagen and endogenous MT1-MMP directly stimulate the cellular activation of pro-MMP2. MT1-LCD, but not MT1-CD, also blocked the cleavage of native type I collagen by MT1-MMP in vitro, indicating an important role for the MT1-MMP linker region in triple helicase activity. Similarly, soluble MT1-LCD, but not MT1-CD or peptide analogs of the MT1-MMP linker, reduced the invasion of type I collagen matrices by MDA-MB-231 cells as did the expression of recombinant 44-kDa MT1-MMP on the cell surface. Together, these studies demonstrate that generation of the 44-kDa MT1-MMP autolysis product regulates collagenolytic activity and subsequent invasive potential, suggesting a novel feedback mechanism for the control of pericellular proteolysis. matrix metalloproteinase membrane type C domain C domain with linker soluble MT1-MMP tissue inhibitor of metalloproteinases Dulbecco's modified Eagle's medium bovine serum albumin concanavalin A phosphate-buffered saline horseradish peroxidase 7-methoxycoumarin-4-yl)acetyl Type I collagen is the most abundant protein of the extracellular matrix and is an important structural component in blood vessels, skin, tendons, ligaments, and bone (1Vuorio E. de Crombrugghe B. Annu. Rev. Biochem. 1990; 59: 837-872Crossref PubMed Scopus (384) Google Scholar). Accordingly, the synthesis and degradation of type I collagen is tightly regulated. Disruptions in this homeostasis can lead to diseases such as pulmonary fibrosis, scleroderma, arthritis, and osteoporosis, which, if untreated, can result in loss of tissue function and integrity. In a number of cancer cells, the capacity to degrade type I collagen and invade through type I collagen matrices often correlates with metastatic potential (2Egeblad M. Werb Z. Nat. Rev. Cancer. 2002; 2: 161-174Crossref PubMed Scopus (5079) Google Scholar), a characteristic that is as important for the local dissemination of tumor cells as type IV collagen degradation and basement membrane penetration is for metastasis (3Stetler-Stevenson W.G. Yu A.E. Semin. Cancer Biol. 2001; 11: 143-152Crossref PubMed Scopus (358) Google Scholar). Despite the importance of maintaining correct collagen homeostasis in tissues, the proteases responsible for type I collagen degradation in vivo remain unclear. An intracellular pathway may play an important role in collagen degradation (4Overall C.M. Sodek J. Davidovitch Z. Biological Mechanisms of Tooth Eruption and Root Resorption. EBSCO Media, Birmingham, Alabama1988: 303-312Google Scholar) that, in bone, utilizes the cysteine protease cathepsin K at low pH (5Saftig P. Hunziker E. Wehmeyer O. Jones S. Boyde A. Rommerskirch W. Moritz J.D. Schu P. von Figura K. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 13453-13458Crossref PubMed Scopus (748) Google Scholar). Extracellularly, fibrillar type I collagen may be degraded at neutral pH by several matrix metalloproteinases (MMPs),1 a 24-member family of zinc-dependent endopeptidases in humans (2Egeblad M. Werb Z. Nat. Rev. Cancer. 2002; 2: 161-174Crossref PubMed Scopus (5079) Google Scholar). The major collagenolytic MMPs are the secreted collagenases, MMP1, MMP8, and MMP13 (6Nagase H. Woessner Jr., J.F. J. Biol. Chem. 1999; 274: 21491-21494Abstract Full Text Full Text PDF PubMed Scopus (3852) Google Scholar), and the cell surface membrane type 1 (MT1)-MMP (7Pei D. Weiss S.J. J. Biol. Chem. 1996; 271: 9135-9140Abstract Full Text Full Text PDF PubMed Scopus (364) Google Scholar, 8Ohuchi E. Imai K. Fujii Y. Sato H. Seiki M. Okada Y. J. Biol. Chem. 1997; 272: 2446-2451Abstract Full Text Full Text PDF PubMed Scopus (828) Google Scholar). MT1-MMP also activates collagenase-2 (MMP13) (9Cowell S. Knauper V. Stewart M.L. D'Ortho M.P. Stanton H. Hembry R.M. Lopez-Otin C. Reynolds J.J. Murphy G. Biochem. J. 1998; 331: 453-458Crossref PubMed Scopus (152) Google Scholar) and is the primary activator of MMP2 (10Sato H. Takino T. Okada Y. Cao J. Shinagawa A. Yamamoto E. Seiki M. Nature. 1994; 370: 61-65Crossref PubMed Scopus (2365) Google Scholar), a gelatinase that exhibits weak native type I collagenolytic activity (11Sodek J. Overall C.M. Matrix Suppl. 1992; 1: 352-362PubMed Google Scholar, 12Aimes R.T. Quigley J.P. J. Biol. Chem. 1995; 270: 5872-5876Abstract Full Text Full Text PDF PubMed Scopus (829) Google Scholar, 13Patterson M.L. Atkinson S.J. Knauper V. Murphy G. FEBS Lett. 2001; 503: 158-162Crossref PubMed Scopus (172) Google Scholar).MMPs share a common overall structure consisting of a propeptide, catalytic domain, linker (also called a hinge), and a hemopexin C domain (14Overall C.M. Methods Mol. Biol. 2001; 151: 79-120PubMed Google Scholar). Whereas the majority of MMPs are secreted as latent zymogens, MT-MMPs, the largest subgroup of MMPs, are membrane-anchored by the presence of a type I transmembrane sequence and cytoplasmic tail (MT1-, MT2-, MT3-, and MT5-MMP) or by glycosylphosphatidylinositol linkage (MT4- and MT6-MMP) (14Overall C.M. Methods Mol. Biol. 2001; 151: 79-120PubMed Google Scholar). MT1-MMP is activated intracellularly by proprotein convertase-dependent and -independent pathways (15Yana I. Weiss S.J. Mol. Biol. Cell. 2000; 11: 2387-2401Crossref PubMed Scopus (268) Google Scholar, 16Rozanov D.V. Deryugina E.I. Ratnikov B.I. Monosov E.Z. Marchenko G.N. Quigley J.P. Strongin A.Y. J. Biol. Chem. 2001; 276: 25705-25714Abstract Full Text Full Text PDF PubMed Scopus (145) Google Scholar) and is expressed as an active protease on the surface of many normal and pathological cell types (10Sato H. Takino T. Okada Y. Cao J. Shinagawa A. Yamamoto E. Seiki M. Nature. 1994; 370: 61-65Crossref PubMed Scopus (2365) Google Scholar, 17Takino T. Sato H. Yamamoto E. Seiki M. Gene (Amst.). 1995; 155: 293-298Crossref PubMed Scopus (93) Google Scholar). The importance of MT1-MMP is indicated by its requirement for the invasion of endothelial and cancer cells through type I collagen matrices (18Galvez B.G. Matias-Roman S. Albar J.P. Sanchez-Madrid F. Arroyo A.G. J. Biol. Chem. 2001; 276: 37491-37500Abstract Full Text Full Text PDF PubMed Scopus (202) Google Scholar, 19Belien A.T. Paganetti P.A. Schwab M.E. J. Cell Biol. 1999; 144: 373-384Crossref PubMed Scopus (202) Google Scholar, 20Aznavoorian S. Moore B.A. Alexander-Lister L.D. Hallit S.L. Windsor L.J. Engler J.A. Cancer Res. 2001; 61: 6264-6275PubMed Google Scholar). Moreover, mice deficient in MT1-MMP developed severe aberrations in type I collagen-abundant tissues, such as bone and skin, and the mice exhibited arthritis and scleroderma (21Holmbeck K. Bianco P. Caterina J. Yamada S. Kromer M. Kuznetsov S.A. Mankani M. Robey P.G. Poole A.R. Pidoux I. Ward J.M. Birkedal-Hansen H. Cell. 1999; 99: 81-92Abstract Full Text Full Text PDF PubMed Scopus (1098) Google Scholar, 22Zhou Z. Apte S.S. Soininen R. Cao R. Baaklini G.Y. Rauser R.W. Wang J. Cao Y. Tryggvason K. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 4052-4057Crossref PubMed Scopus (682) Google Scholar). In humans, homoallelic loss-of-function mutations in the MMP2 gene result in excessive bone resorption and arthritis (23Martignetti J.A. Aqeel A.A. Sewairi W.A. Boumah C.E. Kambouris M. Mayouf S.A. Sheth K.V. Eid W.A. Dowling O. Harris J. Glucksman M.J. Bahabri S. Meyer B.F. Desnick R.J. Nat. Genet. 2001; 28: 261-265Crossref PubMed Scopus (247) Google Scholar). This condition resembles the phenotype of the MT1-MMP knockout mouse, supporting the close functional connection of MMP2 and MT1-MMP in regulating pericellular collagen homeostasis in mice and humans.Native type I collagen consists of two α1(I) chains and one α2(I) chain interwound in a right-handed triple helix that is resistant to cleavage by most proteinases at neutral pH with the exception of the MMP collagenases (14Overall C.M. Methods Mol. Biol. 2001; 151: 79-120PubMed Google Scholar). Because the active site of collagenolytic MMPs can only accommodate a single α-chain, cleavage of the three α-chains occurs sequentially at the single collagenase-susceptible site, Gly775-Ile/Leu776, to generate ¾ and ¼ collagen fragments. To achieve this, the collagen helix must be initially unwound by a triple helicase mechanism in order to expose the scissile bonds. This critical step requires the presence of collagen-binding exosites (14Overall C.M. Methods Mol. Biol. 2001; 151: 79-120PubMed Google Scholar), in addition to elements within the active site (24Knauper V. Patterson M.L. Gomis-Ruth F.X. Smith B. Lyons A. Docherty A.J. Murphy G. Eur. J. Biochem. 2001; 268: 1888-1896Crossref PubMed Scopus (17) Google Scholar, 25Chung L. Shimokawa K. Dinakarpandian D. Grams F. Fields G.B. Nagase H. J. Biol. Chem. 2000; 275: 29610-29617Abstract Full Text Full Text PDF PubMed Scopus (118) Google Scholar, 26Brandstetter H. Grams F. Glitz D. Lang A. Huber R. Bode W. Krell H.W. Engh R.A. J. Biol. Chem. 2001; 276: 17405-17412Abstract Full Text Full Text PDF PubMed Scopus (128) Google Scholar). In MMP1, MMP8, and MMP13, the hemopexin C domain supports binding to collagen and is required for native collagen cleavage (27Allan J.A. Hembry R.M. Angal S. Reynolds J.J. Murphy G. J. Cell Sci. 1991; 99: 789-795Crossref PubMed Google Scholar, 28Clark I.M. Cawston T.E. Biochem. J. 1989; 263: 201-206Crossref PubMed Scopus (160) Google Scholar, 29Windsor L.J. Birkedal-Hansen H. Birkedal-Hansen B. Engler J.A. Biochemistry. 1991; 30: 641-647Crossref PubMed Scopus (72) Google Scholar, 30Murphy G. Allan J.A. Willenbrock F. Cockett M.I. O'Connell J.P. Docherty A.J. J. Biol. Chem. 1992; 267: 9612-9618Abstract Full Text PDF PubMed Google Scholar, 31Knauper V. Osthues A. DeClerck Y.A. Langley K.E. Blaser J. Tschesche H. Biochem. J. 1993; 291: 847-854Crossref PubMed Scopus (99) Google Scholar, 32Knauper V. Cowell S. Smith B. Lopez-Otin C. O'Shea M. Morris H. Zardi L. Murphy G. J. Biol. Chem. 1997; 272: 7608-7616Abstract Full Text Full Text PDF PubMed Scopus (294) Google Scholar). Deletion or mutation of the MMP8 linker also reduces collagenolysis (33Hirose T. Patterson C. Pourmotabbed T. Mainardi C.L. Hasty K.A. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 2569-2573Crossref PubMed Scopus (124) Google Scholar, 34Knauper V. Docherty A.J. Smith B. Tschesche H. Murphy G. FEBS Lett. 1997; 405: 60-64Crossref PubMed Scopus (46) Google Scholar). Furthermore, synthetic peptide analogs of the MMP1 linker bound collagen and inhibited collagen cleavage (35de Souza S.J. Brentani R. J. Biol. Chem. 1992; 267: 13763-13767Abstract Full Text PDF PubMed Google Scholar). Interestingly, the 35-amino acid residue linker of MT1-MMP is twice the length of other collagenase linkers (18 residues); however, the significance of this and its role in collagen cleavage have yet to be examined.The regulation of MT1-MMP activity, MMP2 activation and pericellular type I collagen levels is complex. In a variety of cells, stimulation by fibrillar type I collagen has been shown to increase the cell surface expression of MT1-MMP and induce the cellular activation of pro-MMP2 (36Azzam H.S. Thompson E.W. Cancer Res. 1992; 52: 4540-4544PubMed Google Scholar, 37Gilles C. Polette M. Seiki M. Birembaut P. Thompson E.W. Lab. Invest. 1997; 76: 651-660PubMed Google Scholar, 38Tomasek J.J. Halliday N.L. Updike D.L. Ahern-Moore J.S., Vu, T.K. Liu R.W. Howard E.W. J. Biol. Chem. 1997; 272: 7482-7487Abstract Full Text Full Text PDF PubMed Scopus (165) Google Scholar, 39Haas T.L. Davis S.J. Madri J.A. J. Biol. Chem. 1998; 273: 3604-3610Abstract Full Text Full Text PDF PubMed Scopus (323) Google Scholar, 40Ellerbroek S.M. Fishman D.A. Kearns A.S. Bafetti L.M. Stack M.S. Cancer Res. 1999; 59: 1635-1641PubMed Google Scholar, 41Ruangpanit N. Chan D. Holmbeck K. Birkedal-Hansen H. Polarek J. Yang C. Bateman J.F. Thompson E.W. Matrix Biol. 2001; 20: 193-203Crossref PubMed Scopus (59) Google Scholar, 42Ellerbroek S.M., Wu, Y.I. Overall C.M. Stack M.S. J. Biol. Chem. 2001; 276: 24833-24842Abstract Full Text Full Text PDF PubMed Scopus (146) Google Scholar). This response is in part dependent on β1 integrin clustering and signaling (40Ellerbroek S.M. Fishman D.A. Kearns A.S. Bafetti L.M. Stack M.S. Cancer Res. 1999; 59: 1635-1641PubMed Google Scholar, 42Ellerbroek S.M., Wu, Y.I. Overall C.M. Stack M.S. J. Biol. Chem. 2001; 276: 24833-24842Abstract Full Text Full Text PDF PubMed Scopus (146) Google Scholar, 43Seltzer J.L. Lee A.Y. Akers K.T. Sudbeck B. Southon E.A. Wayner E.A. Eisen A.Z. Exp. Cell Res. 1994; 213: 365-374Crossref PubMed Scopus (122) Google Scholar) and is potentially self-regulating, since type I collagen is susceptible to MT1-MMP and MMP2 proteolysis (14Overall C.M. Methods Mol. Biol. 2001; 151: 79-120PubMed Google Scholar, 44Ellerbroek S.M. Stack M.S. Bioessays. 1999; 21: 940-949Crossref PubMed Scopus (133) Google Scholar). Concentration of MT1-MMP by overexpression (45Butler G.S. Butler M.J. Atkinson S.J. Will H. Tamura T. van Westrum S.S. Crabbe T. Clements J. d'Ortho M.P. Murphy G. J. Biol. Chem. 1998; 273: 871-880Abstract Full Text Full Text PDF PubMed Scopus (538) Google Scholar, 46Hernandez-Barrantes S. Toth M. Bernardo M.M. Yurkova M. Gervasi D.C. Raz Y. Sang Q.A. Fridman R. J. Biol. Chem. 2000; 275: 12080-12089Abstract Full Text Full Text PDF PubMed Scopus (272) Google Scholar) or clustering interactions (47Overall C.M. Tam E. McQuibban G.A. Morrison C. Wallon U.M. Bigg H.F. King A.E. Roberts C.R. J. Biol. Chem. 2000; 275: 39497-39506Abstract Full Text Full Text PDF PubMed Scopus (85) Google Scholar, 48Itoh Y. Takamura A. Ito N. Maru Y. Sato H. Suenaga N. Aoki T. Seiki M. EMBO J. 2001; 20: 4782-4793Crossref PubMed Scopus (337) Google Scholar, 49Lehti K. Lohi J. Juntunen M.M. Pei D. Keski-Oja J. J. Biol. Chem. 2002; 277: 8440-8448Abstract Full Text Full Text PDF PubMed Scopus (115) Google Scholar, 50Overall C.M. Sodek J. J. Biol. Chem. 1990; 265: 21141-21151Abstract Full Text PDF PubMed Google Scholar) favors MMP2 activation and collagenolysis (50Overall C.M. Sodek J. J. Biol. Chem. 1990; 265: 21141-21151Abstract Full Text PDF PubMed Google Scholar). Concomitant with increased MT1-MMP expression and MMP2 activation is the autocatalytic processing of MT1-MMP at Gly284–Gly285 to shed the catalytic domain from the hemopexin C domain, which is retained on the cell membrane (40Ellerbroek S.M. Fishman D.A. Kearns A.S. Bafetti L.M. Stack M.S. Cancer Res. 1999; 59: 1635-1641PubMed Google Scholar, 46Hernandez-Barrantes S. Toth M. Bernardo M.M. Yurkova M. Gervasi D.C. Raz Y. Sang Q.A. Fridman R. J. Biol. Chem. 2000; 275: 12080-12089Abstract Full Text Full Text PDF PubMed Scopus (272) Google Scholar, 51Lehti K. Lohi J. Valtanen H. Keski-Oja J. Biochem. J. 1998; 334: 345-353Crossref PubMed Scopus (201) Google Scholar). Hence, the ectodomain of the residual 44-kDa MT1-MMP fragment (Gly285–Val582) on the cell surface consists of the linker, hemopexin C domain, and stalk segment only (see Fig. 1 A, ii) and thus is catalytically inactive. The significance of the 44-kDa MT1-MMP in vivo is not clear. In addition to being present following cell binding to type I collagen, the 44-kDa MT1-MMP has also been detected on the surface of tumor cells (40Ellerbroek S.M. Fishman D.A. Kearns A.S. Bafetti L.M. Stack M.S. Cancer Res. 1999; 59: 1635-1641PubMed Google Scholar, 51Lehti K. Lohi J. Valtanen H. Keski-Oja J. Biochem. J. 1998; 334: 345-353Crossref PubMed Scopus (201) Google Scholar). During MMP2 activation, TIMP-2-free MT1-MMP must be in close proximity to a trimeric complex of MT1-MMP·TIMP-2·pro-MMP2 in order to activate the bound pro-MMP2 (52Kinoshita T. Sato H. Okada A. Ohuchi E. Imai K. Okada Y. Seiki M. J. Biol. Chem. 1998; 273: 16098-16103Abstract Full Text Full Text PDF PubMed Scopus (258) Google Scholar). The mechanisms of MT1-MMP oligomerization are not clear. The recombinant hemopexin C domain of MT1-MMP did not form oligomers in solution or modulate MMP2 activation when added to cells (47Overall C.M. Tam E. McQuibban G.A. Morrison C. Wallon U.M. Bigg H.F. King A.E. Roberts C.R. J. Biol. Chem. 2000; 275: 39497-39506Abstract Full Text Full Text PDF PubMed Scopus (85) Google Scholar). Recent reports using transmembrane MT1-MMP chimera and deletion mutants have suggested that the hemopexin C domain can mediate homophilic complex formation of cellular MT1-MMP for efficient MMP2 activation (48Itoh Y. Takamura A. Ito N. Maru Y. Sato H. Suenaga N. Aoki T. Seiki M. EMBO J. 2001; 20: 4782-4793Crossref PubMed Scopus (337) Google Scholar, 49Lehti K. Lohi J. Juntunen M.M. Pei D. Keski-Oja J. J. Biol. Chem. 2002; 277: 8440-8448Abstract Full Text Full Text PDF PubMed Scopus (115) Google Scholar). Expression of a transmembrane-tethered MT1-MMP hemopexin C domain lacking the linker, termed PEX (Thr313–Val582), in HT1080 cells inhibited MT1-MMP oligomerization, the cellular activation of pro-MMP2, and Matrigel invasion (48Itoh Y. Takamura A. Ito N. Maru Y. Sato H. Suenaga N. Aoki T. Seiki M. EMBO J. 2001; 20: 4782-4793Crossref PubMed Scopus (337) Google Scholar), a function previously attributed to MMP2 proteolytic activity against type IV collagen (53Albini A. Melchiori A. Santi L. Liotta L.A. Brown P.D. Stetler-Stevenson W.G. J. Natl. Cancer Inst. 1991; 83: 775-779Crossref PubMed Scopus (311) Google Scholar).Considering that MT1-MMP is a collagenase, we hypothesized that exosites on the hemopexin C domain would bind to type I collagen and be essential for collagenolytic activity. Thus, the autolytically generated 44-kDa MT1-MMP ectodomain would be predicted to modulate pericellular collagenolysis on the membrane through dominant-negative interactions. Since native type I collagen stimulates MMP2 activation, we also hypothesized that collagen binding by the hemopexin C domain of MT1-MMP would modulate MMP2 activation with 44-kDa MT1-MMP opposing these effects in vivo. Experiments reported here demonstrate that collagen binding by the MT1-MMP hemopexin C domain is essential for collagenolytic activity and enhancement of MMP2 activation by MT1-MMP. Inhibition of this interaction either in vitro or on the cell surface inhibits collagen degradation. Together, these studies suggest a novel feedback mechanism through which generation of the 44-kDa MT1-MMP autolysis product regulates pericellular collagenolytic activity and subsequent invasive potential.DISCUSSIONAs an integral membrane protein, MT1-MMP appears suited for coordinating the homeostatic catabolism of pericellular type I collagen under the guide of the cell (62Nakahara H. Howard L. Thompson E.W. Sato H. Seiki M. Yeh Y. Chen W.T. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 7959-7964Crossref PubMed Scopus (360) Google Scholar, 63Nabeshima K. Inoue T. Shimao Y. Okada Y. Itoh Y. Seiki M. Koono M. Cancer Res. 2000; 60: 3364-3369PubMed Google Scholar, 64Lehti K. Valtanen H. Wickstrom S. Lohi J. Keski-Oja J. J. Biol. Chem. 2000; 275: 15006-15013Abstract Full Text Full Text PDF PubMed Scopus (144) Google Scholar, 65Hotary K. Allen E. Punturieri A. Yana I. Weiss S.J. J. Cell Biol. 2000; 149: 1309-1323Crossref PubMed Scopus (507) Google Scholar). MT1-MMP mediates collagen degradation directly by cleaving native collagen and, indirectly, by activating MMP13 (9Cowell S. Knauper V. Stewart M.L. D'Ortho M.P. Stanton H. Hembry R.M. Lopez-Otin C. Reynolds J.J. Murphy G. Biochem. J. 1998; 331: 453-458Crossref PubMed Scopus (152) Google Scholar) and the gelatinase and weak collagenase, MMP2 (11Sodek J. Overall C.M. Matrix Suppl. 1992; 1: 352-362PubMed Google Scholar, 12Aimes R.T. Quigley J.P. J. Biol. Chem. 1995; 270: 5872-5876Abstract Full Text Full Text PDF PubMed Scopus (829) Google Scholar, 13Patterson M.L. Atkinson S.J. Knauper V. Murphy G. FEBS Lett. 2001; 503: 158-162Crossref PubMed Scopus (172) Google Scholar). Spatially and temporally, these two distinct activities of MT1-MMP regulate collagenolytic and gelatinolytic activities on the cell surface. Since MT1-MMP is a critical initiator and effector in the pericellular collagenolytic cascade, the regulation of its biological activity is very important in physiological and pathological collagen remodeling. The studies reported here have revealed the importance of the MT1-MMP hemopexin C domain and linker in the mechanism of collagen cleavage and demonstrated the role of collagen binding to MT1-MMP in stimulating MMP2 activation by cells. Moreover, these actions may be modulated in a dominant negative manner by the 44-kDa remnant form of MT1-MMP on the cell surface, revealing a novel regulatory function in proteolysis for an autolytic fragment of a protease.The structure of collagen presents a challenge for proteolytic cleavage, as indicated by the lowk cat/K m values for collagenases (66Welgus H.G. Jeffrey J.J. Stricklin G.P. Roswit W.T. Eisen A.Z. J. Biol. Chem. 1980; 255: 6806-6813Abstract Full Text PDF PubMed Google Scholar). Despite several studies from a number of laboratories, the triple helicase mechanism remains enigmatic (14Overall C.M. Methods Mol. Biol. 2001; 151: 79-120PubMed Google Scholar). Our use of recombinant domains and polypeptides to probe the exosite requirements of MT1-MMP for collagenolysis revealed similar domain requirements for triple helicase activity as the secreted collagenases. The binding of the MT1-MMP hemopexin C domain, with or without the linker, to native collagen is consistent with previous reports for the collagenolytic MMPs (27Allan J.A. Hembry R.M. Angal S. Reynolds J.J. Murphy G. J. Cell Sci. 1991; 99: 789-795Crossref PubMed Google Scholar, 30Murphy G. Allan J.A. Willenbrock F. Cockett M.I. O'Connell J.P. Docherty A.J. J. Biol. Chem. 1992; 267: 9612-9618Abstract Full Text PDF PubMed Google Scholar, 31Knauper V. Osthues A. DeClerck Y.A. Langley K.E. Blaser J. Tschesche H. Biochem. J. 1993; 291: 847-854Crossref PubMed Scopus (99) Google Scholar, 32Knauper V. Cowell S. Smith B. Lopez-Otin C. O'Shea M. Morris H. Zardi L. Murphy G. J. Biol. Chem. 1997; 272: 7608-7616Abstract Full Text Full Text PDF PubMed Scopus (294) Google Scholar). The hemopexin C domain of MMP2, in contrast, does bind native collagen stably (57Wallon U.M. Overall C.M. J. Biol. Chem. 1997; 272: 7473-7481Abstract Full Text Full Text PDF PubMed Scopus (97) Google Scholar). Interestingly, the MT1-MMP hemopexin C domain does not bind denatured collagen. This suggests that, following cleavage, subsequent denaturation of the collagen would result in the release of MT1-MMP from the cleaved substrate facilitating turnover.Inhibition of sMT1-MMP collagen cleavage using MT1-MMP hemopexin C domain constructs required the presence of the linker, indicating that collagen binding, by the hemopexin C domain alone, is not sufficient to disrupt collagenolysis. This requirement was also observed in MMP2 collagenolysis, since MT1-LCD, but not MT1-CD, blocked MMP2 cleavage of native collagen. Protein engineering studies of MMP1 and MMP8 have previously shown a role for the linker in triple helicase activity (33Hirose T. Patterson C. Pourmotabbed T. Mainardi C.L. Hasty K.A. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 2569-2573Crossref PubMed Scopus (124) Google Scholar, 34Knauper V. Docherty A.J. Smith B. Tschesche H. Murphy G. FEBS Lett. 1997; 405: 60-64Crossref PubMed Scopus (46) Google Scholar, 35de Souza S.J. Brentani R. J. Biol. Chem. 1992; 267: 13763-13767Abstract Full Text PDF PubMed Google Scholar); however, our studies have revealed some unique features of the MT1-MMP linker. De Souza et al. (67De Souza S.J. Pereira H.M. Jacchieri S. Brentani R.R. FASEB J. 1996; 10: 927-930Crossref PubMed Scopus (48) Google Scholar) proposed that the MMP1 collagenase linker, due to its proline content, intercalates with the collagen triple helix, thereby displacing individual α-chains for cleavage. We found that MT1-MMP linker peptide analogs of either the full-length 35-amino acid residue linker or the 18-amino acid residue region, corresponding to that found in the secreted collagenases, did not bind native or denatured type I collagen. These results indicate that the MT1-MMP linker may not bind or intercalate with the collagen triple helix as proposed for the MMP1 linker. Indeed, the low glycine content renders triple helix formation by these linkers impossible. Potentially, the full collagen binding exosite of the MT1-MMP hemopexin C domain that recognizes the ¾-¼ collagen site may span the linker/hemopexin C domain junction, thereby accounting for the lack of collagen binding by the linker analogs alone and the ineffectiveness of MTI-CD in blocking collagenolysis. The MT1-MMP linker, when connected to the hemopexin C domain, may act as a specificity determinant directing binding of the protease to the ¾-¼ collagen cleavage site. Thus, competition from MT1-LCD, but not MT1-CD, may block MT1-MMP from binding collagen here and so inhibit cleavage. Topographically, the MT1-MMP, and other collagenase linkers, may also correctly configure the catalytic domain relative to the hemopexin C domain for collagenolytic competence. Indeed, the MT1-MMP linker has predicted rigidity due to the presence of 9 proline residues, and we interpret the x-ray crystallographic structure of the MMP1 linker (68Li J. Brick P. O'Hare M.C. Skarzynski T. Lloyd L.F. Curry V.A. Clark I.M. Bigg H.F. Hazleman B.L. Cawston T.E. Structure. 1995; 3: 541-549Abstract Full Text Full Text PDF PubMed Scopus (238) Google Scholar) to also indicate that the linker is not as flexible as generally thought. Hence, MT1-LCD binding of collagen may sterically disrupt the collagenolytic configuration of sMT1-MMP at the ¾-¼ collagen cleavage site, thereby inhibiting cleavage.The importance of MT1-MMP in collagen homeostasis is supported by the finding that fibrillar type I collagen induces cell surface expression of MT1-MMP and subsequent MMP2 activation through transcriptional and nontranscriptional pathways (36Azzam H.S. Thompson E.W. Cancer Res. 1992; 52: 4540-4544PubMed Google Scholar, 37Gilles C. Polette M. Seiki M. Birembaut P. Thompson E.W. Lab. Invest. 1997; 76: 651-660PubMed Google Scholar, 38Tomasek J.J. Halliday N.L. Updike D.L. Ahern-Moore J.S., Vu, T.K. Liu R.W. Howard E.W. J. Biol. Chem. 1997; 272: 7482-7487Abstract Full Text Full Text PDF PubMed Scopus (165) Google Scholar, 39Haas T.L. Davis S.J. Madri J.A. J. Biol. Chem. 1998; 273: 3604-3610Abstract Full Text Full Text PDF PubMed Scopus (323) Google Scholar, 40Ellerbroek S.M. Fishman D.A. Kearns A.S. Bafetti L.M. Stack M.S. Cancer Res. 1999; 59: 1635-1641PubMed Google Scholar, 41Ruangpanit N. Chan D. Holmbeck K. Birkedal-Hansen H. Polarek J. Yang C. Bateman J.F. Thompson E.W. Matrix Biol. 2001; 20: 193-203Crossref PubMed Scopus (59) Google Scholar, 69Gilles C. Bassuk J.A. Pulyaeva H. Sage E.H. Foidart J.M. Thompson E.W. Cancer Res. 1998; 58: 5529-5536PubMed Google Scholar). Induction of MT1-MMP transcription is dependent on β1 integrin receptors and actin cytoskeleton rearrangement (38Tomasek J.J. Halliday N.L. Updike D.L. Ahern-Moore J.S., Vu, T.K. Liu R.W. Howard E.W. J. Biol. Chem. 1997; 272: 7482-7487Abstract Full Text Full Text PDF PubMed Scopus (165) Google Scholar, 43Seltzer J.L. Lee A.Y. Akers K.T. Sudbeck B. Southon E.A. Wayner E.A. Eisen A.Z. Exp. Cell Res. 19

Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA

Cloning and Expression of the Cdna Encoding Human Tissue Inhibitor of Metalloproteinase-3 and Its Inhibition on Angiogenesis

Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase

Identification of the (183)RWTNNFREY(191) region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity

Collagen Binding Properties of the Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) Hemopexin C Domain

Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates.

Activation-coupled Membrane-Type 1 Matrix Metalloproteinase Membrane Trafficking.

Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): the differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities

Glycosylation Broadens the Substrate Profile of Membrane Type 1 Matrix Metalloproteinase.

Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme

The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity

The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction

Disruption of the cysteine-75 and zinc ion coordination is not sufficient to activate the precursor of human matrix metalloproteinase 3 (stromelysin 1)

Degradomic Identification of Membrane Type 1-Matrix Metalloproteinase as an ADAMTS9 and ADAMTS20 Substrate

Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor

Intracellular MMP3 Promotes HSP Gene Expression in Collaboration With Chromobox Proteins

Identification of collagen binding domain residues that govern catalytic activities of matrix metalloproteinase-2 (MMP-2)

An elastinolytic enzyme detected in the culture medium of human arterial smooth muscle cells

Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis

Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage.

Integrin α3β1 signaling through MEK/ERK determines alternative polyadenylation of the MMP-9 mRNA transcript in immortalized mouse keratinocytes